BioMarin Pharmaceutical Inc. buy BMO Capital Markets
Start price
05.07.23
/
50%
€80.26
Target price
05.07.24
€93.60
Performance (%)
-5.11%
Price
09.05.24
€76.16
Summary
This prediction is currently active. With a performance of -5.11%, the BUY prediction by BMO_Capital_Markets is trending in the wrong direction. This prediction currently runs until 05.07.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -2.509% | -2.509% |
| iShares Core DAX® | 4.015% | 2.971% |
| iShares Nasdaq 100 | 2.755% | 0.503% |
| iShares Nikkei 225® | -0.826% | -5.057% |
| iShares S&P 500 | 2.330% | 0.720% |
Comments by BMO_Capital_Markets for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $102.00 price target on the stock.
Ratings data for BMRN provided by MarketBeat